Physician profile
Thomas W Wise
NPI 1831126663
$2,132.98
in general payments reported to CMS, 2019-2025
12 companies · $15.24 in 2025
The $15.24 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $510 · 2021: $806 · 2022: $37.65 · 2024: $25.31 · 2025: $15.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $980.45 | 2019-2020 | |
| Fortis Surgical, LLC | $400.62 | 2021 | |
| Arthrex, INC. | $367.00 | 2021 | |
| Depuy Synthes Sales INC. | $159.55 | 2020-2022 | |
| Pacira Therapeutics, INC. | $62.89 | 2019-2020 | |
| Biocomposites INC | $40.96 | 2019 | |
| Acacia Pharma INC | $38.63 | 2021 | |
| Inspire Medical Systems, INC. | $25.31 | 2024 | Inspire |
| Mallinckrodt Enterprises LLC | $16.09 | 2019 | |
| Amgen INC. | $15.24 | 2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $13.20 | 2022 | |
| Wright Medical Technology, INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.